Events

IBC Life Sciences' Bioprocess Training Academy course are two-day training sessions that allow you to increase job skills, develop solutions, gain industry insight and expand your network. May: San Diego, CA; June: Cambridge, MA.

IBC's Next Generation Protein Therapeutics Summit is the only conference on the market which consistently brings together every leading company and academic scientist working in alternative scaffold and next-generation protein therapeutic development.

IBC has taken the lead to bring all the industry experts together to give you the answers you need to move ahead your discovery, design or development program. This is the first program to combine coverage of ADCs and other bioconjugates so you can expand your knowledge base and move your programs efficiently ahead from bench to bedside.

IBC's 5th Annual BioProcess International China conference provides you with practical tools, techniques and strategies to improve your upstream and downstream development efforts and offer you insights into state-of-the-art approaches for GMP manufacturing and scale-up that meet international standards.

The biopharmaceutical industry's premier event. It is the one place where you know you will meet with the key players in the field. BPI is your industry resource to expand your knowledge with unparalleled access to new, unpublished data and exclusive case studies from companies of all sizes and perspectives. Your attendance prepares your bioprocess operations for success in the highly dynamic market for biologics.

This is annual forum that focuses on novel predictive methods and technologies for the rational development and production of next-generation biological drug products. This 2013 program embraces regulatory aspects of such issues as aggregation and immunogenicity to utilizing biosimilars in therapeutic and biologic development.

IBC's Well Characterized Biologicals conference is the leading industry conference to provide case studies, CMC strategies and regulatory perspectives on protein characterization and product comparability for biotechnology products and biosimilars throughout the product lifecycle.

IBC's Inaugural Product and Process Variants & Impurities conference explores the major classes of productand process-related impurities that can affect the safety, efficacy, and overall structure of a molecule targeted for a biologic or protein therapeutic.

IBC's Antibody Engineering & Therapeutics meeting has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to find new approaches to developing novel medicines and vaccines and to improve the safety and efficacy of antibody therapeutics now in development.